Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-18-002790

Chief Executive Officer acquired 34,380 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Carpenter George C IV Chief Executive Officer 2018-04-19 Grant or award +34,380 39,708 D
Loading xslF345X03/s109724_form4.xml…